✦ LIBER ✦

Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer

✍ Scribed by Liang, Yonggang; Guo, Shanxian; Zhou, Qinghua

Book ID: 121591206
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 334 KB
Volume: 35
Category: Article
ISSN: 1010-4283
DOI: 10.1007/s13277-013-1491-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of matrix metalloprotei

Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer

✍ Wen-Jia Peng; Jun-Qing Zhang; Bing-Xiang Wang; Hai-Feng Pan; Man-Man Lu; Jing Wa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 724 KB

Expression of matrix metalloproteinases

Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer

✍ Leinonen, Tero; Pirinen, Risto; Böhm, Jan; Johansson, Risto; Ropponen, Kirsi; Ko 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 363 KB

Prognostic value of HMGB3 expression in

Prognostic value of HMGB3 expression in patients with non-small cell lung cancer

✍ Ning Song, Bao Liu, Jian-Ling Wu, Rui-Fang Zhang, Lin Duan, Wen-Shu He… 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 226 KB

Prognostic value of xanthine oxidoreduct

Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer

✍ Kim, Anthony W.; Batus, Marta; Myint, Ronald; Fidler, Mary J.; Basu, Sanjib; Bon 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Prognostic value of microRNA expression

Prognostic value of microRNA expression in operable non-small cell lung cancer patients

✍ Skrzypski, M; Czapiewski, P; Goryca, K; Jassem, E; Wyrwicz, L; Pawłowski, R; Rzy 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 479 KB

Prognostic impact of matrix metalloprote

Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer

✍ Wulf Sienel; Joe Hellers; Alicia Morresi-Hauf; Ralf Lichtinghagen; Wolf Mutschle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 1 views

## Abstract We assessed the clinical impact of MMP‐9 expression on long‐term survival in patients with operable non‐small cell lung cancer (NSCLC). Primary tumors of 143 consecutive patients with NSCLC resected completely and without overt distant metastases (pT1‐4, pN0‐2, M0, R0) were examined for